Cadence, a provider of remote patient monitoring and virtual care services, has come out of stealth mode with $41 million in funding from rounds led by General Catalyst and Thrive Capital, Med City News reports. The New York City-based company has also forged a partnership with Brentwood, Tennessee-based LifePoint Health. Read more.
Related Posts
Vedanta Biosciences Completes $68M Series D Round
Vedanta Biosciences, Inc., a leading clinical-stage microbiome company developing a new category of oral therapies using defined bacterial consortia manufactured from clonal cell banks, today announced the closing of the Series D financing and provided a pipeline update.
July 21, 2021
Texas-Based Health Tech Company Seeks to Raise $1.8M
VivoDoc is a web and mobile marketplace where patients can search for physicians, self-book appointments, determine if their insurance is accepted, and more.
January 19, 2023